INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 155 filers reported holding INARI MED INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,937,000 | +56.1% | 44,906 | +38.7% | 0.00% | – |
| Q2 2023 | $1,882,000 | +92.8% | 32,368 | +104.7% | 0.00% | – |
| Q1 2023 | $976,000 | -38.2% | 15,815 | -36.4% | 0.00% | – |
| Q4 2022 | $1,579,000 | +31.3% | 24,852 | +50.1% | 0.00% | – |
| Q3 2022 | $1,203,000 | +13.1% | 16,552 | +5.8% | 0.00% | – |
| Q2 2022 | $1,064,000 | -37.8% | 15,652 | -17.0% | 0.00% | – |
| Q1 2022 | $1,710,000 | -25.1% | 18,854 | -24.6% | 0.00% | -100.0% |
| Q4 2021 | $2,283,000 | +32.9% | 25,020 | +18.1% | 0.00% | – |
| Q3 2021 | $1,718,000 | -0.9% | 21,186 | +14.0% | 0.00% | – |
| Q2 2021 | $1,733,000 | -10.6% | 18,580 | +2.5% | 0.00% | -100.0% |
| Q1 2021 | $1,939,000 | +59.2% | 18,118 | +29.9% | 0.00% | – |
| Q4 2020 | $1,218,000 | +2547.8% | 13,952 | +1998.0% | 0.00% | – |
| Q3 2020 | $46,000 | +70.4% | 665 | +17.7% | 0.00% | – |
| Q2 2020 | $27,000 | – | 565 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |